COVID-19 Prevalence among Healthcare Workers. A Systematic Review and Meta-Analysis.

COVID-19 SARS-CoV-2 healthcare worker meta-analysis systematic review

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
23 Dec 2021
Historique:
received: 26 11 2021
revised: 18 12 2021
accepted: 20 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 14 1 2022
Statut: epublish

Résumé

Understanding the burden of SARS-CoV-2 infections among healthcare workers is a critical component to inform occupational health policy and strategy. We conducted a systematic review and meta-analysis to map and analayse the available global evidence on the prevalence of SARS-CoV-2 infections among healthcare workers. The random-effects adjusted pooled prevalence of COVID-19 among those studies that conducted the test using the antibody (Ab) method was 7% [95% CI: 3 to 17%]. The random-effects adjusted pooled prevalence of COVID-19 among those studies that conducted the test using the PCR method was 11% [95% CI: 7 to 16%]. We found the burden of COVID-19 among healthcare workers to be quite significant and therefore a cause for global health concern. Furthermore, COVID-19 infections among healthcare workers affect service delivery through workers' sick leave, the isolation of confirmed cases and quarantine of contacts, all of which place significant strain on an already shrunken health workforce.

Identifiants

pubmed: 35010412
pii: ijerph19010146
doi: 10.3390/ijerph19010146
pmc: PMC8750782
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
Diseases. 2021 May 04;9(2):
pubmed: 34064390
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
PLoS One. 2021 May 3;16(5):e0250602
pubmed: 33939733
EClinicalMedicine. 2021 Nov;41:101172
pubmed: 34723165
PLoS One. 2021 May 4;16(5):e0250958
pubmed: 33945546
Pan Afr Med J. 2020 Apr 30;35(Suppl 2):13
pubmed: 32528624
Public Health Pract (Oxf). 2021 Nov;2:100086
pubmed: 34494007
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
BMC Med Res Methodol. 2020 Apr 26;20(1):96
pubmed: 32336279
Public Health Pract (Oxf). 2020 Nov;1:100038
pubmed: 34173573
Scand J Immunol. 2021 Jun;93(6):e13039
pubmed: 33710663
Nat Med. 2021 Jun;27(6):964-980
pubmed: 34002090
Int J Environ Res Public Health. 2021 Oct 03;18(19):
pubmed: 34639712
Int J Infect Dis. 2021 Aug;109:244-246
pubmed: 34260956
BMJ. 2015 Mar 16;350:h870
pubmed: 25775931
Nat Med. 2020 Aug;26(8):1218-1223
pubmed: 32581323
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Virol J. 2021 Mar 17;18(1):58
pubmed: 33731169
Saf Health Work. 2020 Sep;11(3):262-265
pubmed: 32995051

Auteurs

Tafadzwa Dzinamarira (T)

School of Health Systems & Public Health, University of Pretoria, Pretoria 0002, South Africa.
ICAP at Columbia University, Harare, Zimbabwe.

Grant Murewanhema (G)

Unit of Obstetrics and Gynaecology, Department of Primary Health Care Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Malizgani Mhango (M)

School of Public Health, University of Western Cape, Cape Town 7535, South Africa.

Patrick Gad Iradukunda (PG)

London School of Hygiene and Tropical Medicine, University of London, London WC1E 7HT, UK.

Itai Chitungo (I)

Faculty of Medicine, College of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Moreblessing Mashora (M)

Department of Public Health, Mount Kenya University, Kigali 00100, Rwanda.

Pelagia Makanda (P)

Department of Medicine, Jinzhou Medical University, Jinzhou 121001, China.

James Atwine (J)

Department of Medicine, Jinzhou Medical University, Jinzhou 121001, China.

Munashe Chimene (M)

Department of Health Sciences, Africa University, Mutare, Zimbabwe.

Elliot Mbunge (E)

Department of Information Technology, Faculty of Accounting and Informatics, Durban University of Technology, Durban 4000, South Africa.

Munyaradzi Paul Mapingure (MP)

ICAP at Columbia University, Harare, Zimbabwe.

Innocent Chingombe (I)

ICAP at Columbia University, Harare, Zimbabwe.

Godfrey Musuka (G)

ICAP at Columbia University, Harare, Zimbabwe.

Sphamandla Josias Nkambule (SJ)

Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban 4001, South Africa.

Bernard Ngara (B)

Faculty of Medicine, College of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH